Baxter International | BAX - Ebitda





Ebitda Changement Date
Abbott USD 2.43B 844M 2026-03
AngioDynamics USD 5.94M 3.78M 2025-09
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 27.28M 10.21M 2026-06
Baxter International USD 309M 756M 2026-03
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Boston Scientific USD 1.63B 27M 2026-06
Cooper Companies USD 67.9M 255.5M 2026-03
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Fresenius EUR 988M 37M 2026-06
Globus Medical USD 279.84M 48.01M 2026-06
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
ICU Medical USD 110.03M 11.35M 2026-06
Insulet USD 199.8M 18.1M 2026-06
Integra LifeSciences USD 78.41M 2.23M 2026-06
Intuitive Surgical USD 1.06B 29.9M 2026-03
J&J USD 8.27B 1.08B 2026-03
Laboratory Of America USD 767.7M 162.1M 2026-06
Medtronic USD 2.63B 174M 2026-06
Merit Medical Systems USD 104.39M 10.97M 2026-06
Quest Diagnostics USD 648M 91M 2026-06
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.93B 357M 2026-06
Tandem Diabetes Care USD 6.42M 3.69M 2026-06
Teleflex USD 75.63M 171.44M 2026-03
Terumo JPY 116.67B 58.79B 2026-06
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06